Skip to main content
Equibles

HANTZ FINANCIAL SERVICES, INC.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1071061 SOUTHFIELD, MI
Back to BMRN Full portfolio

Position in BMRN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$653,681
+$13,198 QoQ
Shares Held
11,424
+0.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#317
of 565 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HANTZ FINANCIAL SERVICES, INC. holds $21,275,017 across 57 Biotechnology names. BMRN ranks #8 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 15,883 $4,781,259
2 HALO
Halozyme Therapeutics, Inc.
 58,496 $4,578,481
3 ARGX
Argenx SE
 2,816 $2,612,600
4 ROIV
Roivant Sciences Ltd.
 34,865 $1,233,872
5 JAZZ
Jazz Pharmaceuticals plc
 3,961 $954,482
6 EXEL
Exelixis, Inc.
 16,074 $874,586
7 CYTK
Cytokinetics Inc
 10,063 $857,266
8 BMRN
Biomarin Pharmaceutical Inc
This page 		11,424 $653,681

All Filings in BMRN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $653,681 11,424
2026-03-31 $640,483 11,338
2025-12-31 $324,190 5,455
2025-09-30 $84,218 1,555
2025-06-30 $58,048 1,056
2025-03-31 $12,865 182
2024-12-31 $7,953 121
2024-09-30 $8,505 121
2024-06-30 $6,421 78
2024-03-31 $6,812 78
2023-12-31 $8,677 90
2023-09-30 $7,963 90
2023-06-30 $7,801 90
2023-03-31 $13,905 143
2022-12-31 $14,799 143
2022-09-30 $15,597 184
2022-06-30 $15,496 187
2022-03-31 $16,653 216
2021-12-31 $977,239 11,061
2021-09-30 $794,541 10,280
2021-06-30 $659,259 7,901
2021-03-31 $563,606 7,464
2020-12-31 $699,152 7,973
2020-09-30 $597,836 7,858
2020-06-30 $878,920 7,126
2020-03-31 $612,540 7,249